¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"solid phase immunoassay"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® solid tumor ÇÑ±Û °íÇüÁ¾¾ç
¼³¸í   
  ¼¼Æ÷·Î ²Ë Âù Á¾¾çÀ» ¸»ÇÔ. ¹éÇ÷º´ µîÀÇ Ç÷¾×¾Ï°ú °°ÀÌ ÇüŸ¦ ÃëÇÏÁö ¾Ê°í ¾×üÀΠ»óÅÂÀÇ ¾Ï°ú ´ëÁ¶µÇ´Â ¿ë¾î·Î¼­ ´Ü´ÜÇÑ µ¢¾î¸®·Î ±¸¼ºµÈ ¾Ç¼ºÁ¾¾çÀÌ´Ù. ´ëºÎºÐÀÇ Á¾¾çÀÌ ÀÌ¿¡ ÇØ´çÇÑ´Ù. Æ¯È÷ Ç¥ÇÇÁ¶Á÷¿¡¼­ ±â¿øÇÑ Á¾¾çÀ» ¸»ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid phase
    °íü»ó
  • solid phase radioimmunoassay
    °íü»ó¹æ»ç¸é¿ªÃøÁ¤(¹ý)
  • competitive immunoassay
    °æÀï¸é¿ªºÐ¼®(¹ý)
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • fluorescence immunoassay
    Çü±¤¸é¿ªºÐ¼®(¹ý)
  • immunoassay
    ¸é¿ªºÐ¼®(¹ý)
  • nephelometric immunoassay
    ȥŹ¸é¿ªºÐ¼®(¹ý), ºñŹ¸é¿ªºÐ¼®(¹ý)
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • solid
    1. °íü-, °íÇü- 2. °íÇü¹°
  • solid cancer
    °íÇü¾Ï
  • solid component
    °íÇü¼ººÐ
  • solid diet
    °íÇüÀ½½Ä
  • solid medium
    °íÇü¹èÁö
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid phase
    °íü»ó
  • solid component
    °íÇü¼ººÐ
  • solid diet
    °íÇü½ÄÀÌ
  • solid organ
    ½ÇÁú±â°ü, ½ÇÁúÀå±â, °íÇüÀå±â
  • solid
    °íü-, °íÇü-, °íÇü¹°
  • solid tumor
    °íÇüÁ¾¾ç
  • luteal phase endometrial biopsy
    Ȳü±âÀڱ󻸷»ý°Ë
  • phase contrast
    À§»ó´ëÁ¶
  • luteal phase defect
    Ȳü±â°á¼Õ
  • phase difference
    À§»óÂ÷
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase
    »ó, ±â, À§»ó
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • latent phase
    ÀáÀç±â , Àẹ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid phase
    °íü»ó
  • solid phase radioimmunoassay
    °íÇü»ó¹æ»ç¸é¿ªÃøÁ¤(¹ý)
  • competitive immunoassay
    °æÀï¸é¿ªºÐ¼®(¹ý)
  • enzyme immunoassay
    È¿¼Ò¸é¿ªºÐ¼®(¹ý)
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªºÐ¼®(¹ý)
  • fluorescence immunoassay
    Çü±¤¸é¿ªºÐ¼®(¹ý)
  • fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀ̸鿪ºÐ¼®(¹ý), Çü±¤µé¶äÀüÀ̸鿪ºÐ¼®(¹ý)
  • immunoassay
    ¸é¿ªºÐ¼®(¹ý)
  • nephelometric immunoassay
    ȥŹ¸é¿ªºÐ¼®(¹ý)
  • particle immunoassay
    ÀÔÀڸ鿪ºÐ¼®(¹ý)
  • prosthetic group-labeled immunoassay
    º¸Á¶±ºÇ¥Áö¸é¿ªºÐ¼®(¹ý)
  • substrate-labeled fluorescence immunoassay
    ±âÁúÇ¥ÁöÇü±¤¸é¿ªºÐ¼®(¹ý)
  • solid cancer
    °íÇü¾Ï
  • solid diet
    °íÇü½ÄÀÌ, ±»ÀºÀ½½Ä
  • solid state electrode
    °íüÀü±Ø
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • EMMIA => enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý¸Å°³¸é¿ªÃøÁ¤
  • FETI => fluorescence excitation transfer immunoassay
    Çü±¤¿©±âÀüÀÌ¸é¿ªÃøÁ¤(¹ý)
  • PCFIA => particle concentration fluorescence immunoassay
    ÀÔÀÚ³óÃàÇü±¤¸é¿ªÃøÁ¤(¹ý)
  • PETINIA => particle-enhanced turbidimetric inhibition immunoassay
    ÀÔÀÚÁõ´ëºñʾïÁ¦¸é¿ªÃøÁ¤(¹ý)
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • homogeneous immunoassay
    ±ÕÁú¸é¿ªÃøÁ¤(¹ý)
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • immunoassay
    ¸é¿ªÇÐÀû ÃøÁ¤(¹ý)
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • immunoassay
    ¸é¿ªÇÐÀû °ËÁ¤(¹ý).
  • prosthetic group-labeled immunoassay
    º¸Á¶±ºÇ¥Áö¸é¿ªÃøÁ¤(¹ý)
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • DNA synthetic phase
    DNA ÇÕ¼º±â
  • Go phase
    Go±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid phase
    °íü»ó(ͳô÷ßÓ)
  • solid phase
    °íü»ó(ͳô÷ßÓ).
  • luteal phase progestational phase
    Ȳ(»ö)ü±â
  • automated immunoassay
    ÀÚµ¿¸é¿ªºÐ¼®
  • channeling immunoassay
    Åë·Î(È­)¸é¿ªÃøÁ¤
  • competitive immunoassay
    °æÇÕ(Àû)¸é¿ªÃøÁ¤(¹ý)
  • defect of canalization (solid lacrimal duct)
    °üÇü¼º°áÇÔ (´«¹°°üÆó¼âÁõ)
  • enzyme immunoassay
    È¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • enzyme immunoassay (EIA)
    È¿¼Ò¸é¿ªÃøÁ¤¹ý
  • enzyme immunoassay(EIA)
    È¿¼Ò ¸é¿ªÃøÁ¤¹ý
  • enzyme modulator mediated immunoassay
    È¿¼ÒÁ¶Àý(º¯Á¶)¸Å°³¸é¿ªÃøÁ¤(¹ý)
  • enzyme-multiplied/mediated immunoassay
    È¿¼Ò´ÙÁß/¸Å°³ ¸é¿ªÃøÁ¤(¹ý)
  • fluorescence correlation immunoassay
    Çü±¤»ó°ü¸é¿ªÃøÁ¤(¹ý)
  • fluorescence immunoassay
    Çü±¤¸é¿ªÃøÁ¤(¹ý)
  • fluorescence polarization immunoassay
    Çü±¤Æí±¤¸é¿ªÃøÁ¤(¹ý)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Luteal phase [Progestational phase]
    Ȳ(»ö)ü±â
    [¿¾ ¿ë¾î] Ȳü±â
  • Leptotene phase
    °¡´Â¼¶À¯±â
    [¿¾ ¿ë¾î] ¼¼»ç±â
  • Phase of cornification
    °¢Áú±â
    [¿¾ ¿ë¾î] °¢ÁúÈ­±â
  • Diplotene phase
    °ã¼¶À¯±â
    [¿¾ ¿ë¾î] ¹è»ç±â
  • Pachytene phase
    ±½Àº¼¶À¯±â
    [¿¾ ¿ë¾î] ÈÄ»ç±â
  • Ovogenetic phase
    ³­Àڹ߻ý±â
    [¿¾ ¿ë¾î] ³­Àڹ߻ý±â
  • Follicular phase
    ³­Æ÷±â
    [¿¾ ¿ë¾î] ³­Æ÷±â
  • Bilateral phase
    ´ëαâ
    [¿¾ ¿ë¾î] ¾çÃø»ó
  • Phase of desquamation
    ¹Ú¸®±â
    [¿¾ ¿ë¾î] ¹Ú¸®±â
  • Phase of incornification
    ºñ°¢Áú±â
    [¿¾ ¿ë¾î] ºñ°¢ÁúÈ­±â
  • Unequal phase
    ºñ´ëαâ
    [¿¾ ¿ë¾î] ºÎµî»ó
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
  • Lactiferous phase
    ¼öÀ¯±â
    [¿¾ ¿ë¾î] ¼öÀ¯±â
  • Synaptic phase
    ¿¬Á¢±â
    [¿¾ ¿ë¾î] ¿¬Á¢±â
  • Menstrual phase
    ¿ù°æ±â
    [¿¾ ¿ë¾î] ¿ù°æ±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocytic phase
    ÀûÇ÷±¸³»¹ßÀ°±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid phase synthesis
    °í»óÇÕ¼º(ͳßÒùêà÷)
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª(ý£áÈØóæ¹)¾Æ½êÀÌ
  • immunoassay
    ¸é¿ª(Øóæ¹)¾Æ½êÀÌ
  • particle immunoassay
    ÀÔÀÚ ¸é¿ª(Ø£í­Øóæ¹)¾Æ½êÀÌ
  • gas solid chromatography
    °³½º °íü(ͳô÷) Å©·Î¸¶Åä±×·¡ÇÇ
  • liquid-solid chromatography
    ¾×ü-°íü(äûô÷ͳô÷) Å©·Î¸¶Åä±×·¡ÇÇ
  • solid medium
    °íÇü¹èÁö(ͳû¡ÛÆò¢)
  • solid scintillation counter
    °í»ó¼¶±¤°è¼ö±â(ͳßÒàìÎÃͪâ¦Ðï)
  • solid scintillation fluorography
    °í»ó¼¶±¤Çü±¤¹ý(ͳßÒàìÎÃû«ÎÃÛö)
  • solid substrate room temperature phosphorescence
    °íü±âÁú ½Ç¿ÂÀα¤¹ý(ͳô÷Ðñòõ ãøè®ìÝÎÃÛö)
  • aqueous phase separator centrifugation
    ¾×»ó ºÐ¸®Ã¼ ¿ø½ÉºÐ¸® (äûßÒ ÝÂ×îô÷ êÀãýÝÂ×î)
  • carboxylation phase
    Ä«¸£º¹½ÇÈ­(ûù)±â(Ñ¢)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • decline phase
    "°¨Åð±â(Êõ÷ÜÑ¢), (ÔÒ) death phase"
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunoassay
    ¸é¿ªÇÐÀû°ËÁ¤¹ý
  • solid
    °íüÀÇ, °íÇüÀÇ
  • solid element
    °íü¼ÒÀÚ
  • solid organ
    ½ÇÁú±â°ü, ½ÇÁúÀå±â
  • solid tumor
    Ãæ½Ç¼ºÁ¾¾ç
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • arterial phase
    µ¿¸Æ±â
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • equilibrium phase
    ÆòÇü±â
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • in phase
    µ¿À§»ó
  • in-phase image
    À§»ó³»¿µ»ó
  • intravoxel phase dispersion
    º¹¼¿³»À§»óÈ®»ê
  • out of phase
    Å»À§»óÀÇ
  • out of phase gradient echo image
    Å»À§»ó°æ»ç¿¡ÄÚ¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SPIA solid-phase immunoabsorption; solid-phase immunoassay
SPIF solid-phase immunoassay fluorescence
FIA fistula in ano; fluorescent immunoassay; focal immunoassay; Freund incomplete adjuvant
SP sacroposterior; sacrum to pubis; salivary progesterone; schizotypal personality; semi-private [room]...
SPPS solid phase peptide synthesis; stable plasma protein solution
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
SPRIA Solid Phase Radioimmune Assay
HS-SPME Headspace solid phase microextraction
MSPD Matrix Solid-Phase Dispersion
SPE Solid Phase Extraction
SPME Solid Phase Micro-Extraction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • enzyme immunoassay
    È¿¼Ò ¸é¿ª ÃøÁ¤¹ý
    ¼Ò·®ÀÌ¶óµµ ±× Ȱ¼ºÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °í°¨µµÀÇ È¿¼Ò¸¦ Ç¥½ÃÀÚ·Î Çϰí Ç׿ø ȤÀº Ç×ü, ³ª¾Æ°¡¼­´Â ƯÀÌÀûÀ¸·Î ¹ÝÀÀÇÏ´Â ¹°Áú, lectin, C1q µîÀ» È­ÇÐÀûÀ¸·Î °áÇÕ½ÃÄÑ, Ç׿ø ȤÀº Ç×ü µûÀ§¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • fluorescence excitation transfer immunoassay
    Çü±¤ ¿©±â ÀüÀÌ ¸é¿ª ÃøÁ¤
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤, ºÒ±ÕÀÏ È¿¼Ò ¸é¿ªÇÐÀû ÃøÁ¤¹ý
  • homogeneous immunoassay
    ±ÕÁú ¸é¿ª ÃøÁ¤, ±ÕÁú ¸é¿ª ÃøÁ¤¹ý
  • immunoassay test
    ¸é¿ª ºÐ¼®¹ý
    Ç׿ø¿¡ ´ëÇÑ Ç×ü°¡ °áÇÕÇÏ´Â ¹ÝÀÀÀº ±ØÈ÷ ƯÀÌÀûÀÎ °ÍÀ̰í Ç׿ø°ú Ç×ü°¡ ¹Ì·®ÀÌ¶óµµ ¹ÝÀÀÀº ÀϾ°í ¶Ç ±× °áÇÕ¹°Àº ¾ÈÁ¤ÇÏ´Ù. ÀÌ¿Í °°Àº Ç׿ø Ç×ü ¹ÝÀÀÀÇ Æ¯Â¡À» ÀÌ¿ëÇÔÀ¸·Î¼­ ¹Ì·®ÀÇ Ç׿øÀ̳ª Ç×ü¸¦ ÃøÁ¤ÇÏ´Â ¹æ¹ýÀÌ´Ù.
  • interstitial solid solution
    ħÀÔÇü °í¿ëü
    ¿ë¸Å ±Ý¼ÓÀÇ °áÁ¤°ÝÀÚ »çÀÌ¿¡ ¿ëÁú ¿øÀÚ°¡ µé¾î°£ ±¸Á¶ÀÇ °í¿ëü.
  • semi-solid
    ¹Ý°íÇü
  • solid basaloid
    Ãæ½Ç¼º ±âÀú»ó
  • solid carbon dioxide therapy
    °íü ź»ê °¡½º ¿ä¹ý
  • solid diet
    °íÇü ½ÄÀÌ
  • solid lesion
    °íüȭ º´¼Ò
  • solid organ
    ½ÇÁú ±â°ü, ½ÇÁú Àå±â
  • solid solution
    °í¿ëü
    1. °íü »óÅ¿¡¼­ ¿ë¸Å ¿øÀÚ¿Í ¿ëÁú ¿øÀÚ°¡ ¼­·Î ³ì¾Æ ÀÖ´Â ÇÕ±Ý. 2. ¹°¿¡ ½Ä¿°À» ¼¯¾î¼­ ´ÜÀÏ»óÀÇ ¿ë¾×À» ¸¸µå´Â °Í°ú °°ÀÌ, °íü »óÅ¿¡¼­µµ ÇÑ ±Ý¼Ó¿¡ ´Ù¸¥ ±Ý¼Ó ¶Ç´Â ºñ±Ý¼ÓÀÌ ¼¯¿© µé¾î°¡ ´ÜÀÏ»óÀÇ °íü »óÅÂÀÇ ¿ë¾×À» ¸¸µå´Â °æ¿ì°¡ Àִµ¥ À̰ÍÀÌ °í¿ëüÀÌ´Ù.
  • solid sound
    ±Ý¼Ó¼ºÀÇ ¼Ò¸®
  • solid-state laser
    °íü ·¹ÀÌÀú
    °íü ¹°ÁúÀÌ µµÆ÷µÈ º¸Åë ¹Ì·® ¿ø¼Ò·Î °áÁ¤ ¼ÒÁÖ¸¦ Ȱ¼º ¸ÅÁú·Î »ç¿ëÇÏ´Â ·¹ÀÌÀú. 2±Ø Áø°ø°ü ¶Ç´Â ¹ÝµµÃ¼ ·¹ÀÌÀú´Â º¸Åë °íü ·¹ÀÌÀú¶ó´Â Á¤ÀÇ¿¡ ÀûÇÕÇÏÁö¸¸ ÀÌ ±º¿¡¼­ Á¦¿ÜµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
solid phase immunoassay Immunoassay in which the antigen or serum is bound to a solid surface, such as a microplate wall or the sides of a tube, the other reactants being free in solution.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
microparticle enzyme immunoassay A technique in which the solid-phase support consists of very small microparticles in liquid suspension. Specific reagent antibodies are covalently bound to the microparticles. Antigen, if present, is then "sandwiched" between bound antibodies and antigen-specific, enzyme-labelled antibodies. Antigen-antibody complexes are detected and quantitated by analysis of fluorescence from the enzyme-substrate interaction.
Acronym: MEIA
(05 Mar 2000)
double antibody immunoassay A method of separating antibody-bound antigen (e.g., insulin) from free antigen by precipitating the former with antibody specific for immunoglobulin.
Synonym: double antibody immunoassay, double antibody method.
(05 Mar 2000)
immunoassay <investigation> A process that measures and identifies a specific biological substance such as an antigen.
(09 Oct 1997)
thin-layer immunoassay A method for detection of antigen-antibody reactions, applicable to detection of either antigen or antibody, based on the fact that either reactant, when added to a polystyrene surface (such as a well in a polystyrene plate) is adsorbed as a thin layer and acts as an immunosorbent capable of binding with the second reactant.
(05 Mar 2000)
enzyme immunoassay The general term for an expanding technical arsenal of testing which allows a full range of quantitative analyses for both antigen and antibodies. These tests use colour-changed products of enzyme-substrate interaction (or inhibition) to measure the antigen-antibody reaction. Examples of EIA procedures (EMIT, ELISA, MAC, MEIA) follow.
Acronym: EIA
(05 Mar 2000)
enzyme-multiplied immunoassay technique A type of immunoassay in which the ligand is labelled with an enzyme, and the enzyme-ligand-antibody complex is enzymatically inactive, allowing quantitation of unlabelled ligand.
The test uses antibodies that react only with the particular drug for which the sample is being tested. The antibodies attach themselves to the drug if it is present in the sample. It is not designed to measure amounts of the drug present, only to detect its presence or absence.
It is used predominantly, but not exclusively, for the detection of drugs of abuse in the urine.
See: competitive binding assay, enzyme-linked immunosorbent assay.
(05 Mar 2000)
fluorescence immunoassay <technique> A sensitive technique which uses fluorescein, a fluorescent molecule, to measure the antigen or antibody concentration in a solution.
(09 Oct 1997)
fluorescence polarisation immunoassay A technique which takes advantage of the increased polarisation (non-random propagation of emission) of fluorescent light emissions when a fluorescent labelled antigen is bound by reagent antibody. The higher the concentration of unlabelled patient antigen present in the test mixture, the less bound fluorescent antigen is present and, consequently, the lower the polarisation of the fluorescent light emission. Standard calibration yields quantitative results.
(05 Mar 2000)
fluorescence polarization immunoassay Fluoroimmunoassay where detection of the hapten-antibody reaction is based on measurement of the increased polarization of fluorescence-labelled hapten when it is combined with antibody. The assay is very useful for the measurement of small haptenic antigens such as drugs at low concentrations.
(12 Dec 1998)
colour solid A schematic arrangement of colour in space, the attributes of hue, saturation, and brightness being represented by cylindrical coordinates.
(05 Mar 2000)
municipal solid waste Garbage. Refuse offering the potential for energy recovery; includes residential, commercial, and institutional wastes.
(05 Dec 1998)
solid 1. Having the constituent parts so compact, or so firmly adhering, as to resist the impression or penetration of other bodies; having a fixed form; hard; firm; compact; opposed to fluid and liquid or to plastic, like clay, or to incompact, like sand.
2. Not hollow; full of matter; as, a solid globe or cone, as distinguished from a hollow one; not spongy; dense; hence, sometimes, heavy.
3. <mathematics> Having all the geometrical dimensions; cubic; as, a solid foot contains 1,728 solid inches.
In this sense, cubics now generally used.
4. Firm; compact; strong; stable; unyielding; as, a solid pier; a solid pile; a solid wall.
5. Applied to a compound word whose parts are closely united and form an unbroken word; opposed to hyphened.
6. Worthy of credit, trust, or esteem; substantial, as opposed to frivolous or fallacious; weighty; firm; strong; valid; just; genuine. "The solid purpose of a sincere and virtuous answer." (Milton) "These, wanting wit, affect gravity, and go by the name of solid men." (Dryden) "The genius of the Italians wrought by solid toil what the myth-making imagination of the Germans had projected in a poem." (J. A. Symonds)
7. Sound; not weakly; as, a solid constitution of body.
8. <botany> Of a fleshy, uniform, undivided substance, as a bulb or root; not spongy or hollow within, as a stem.
9. <psychology> Impenetrable; resisting or excluding any other material particle or atom from any given portion of space; applied to the supposed ultimate particles of matter.
10. Not having the lines separated by leads; not open.
11. United; without division; unanimous; as, the delegation is solid for a candidate. Solid angle.
<geometry> See Angle. Solid colour, an even colour; one not shaded or variegated. Solid green. See Emerald green, under Green.
<mathematics> Solid measure, a square body or troops in which the ranks and files are equal.
Synonym: Hard, firm, compact, strong, substantial, stable, sound, real, valid, true, just, weighty, profound, grave, important.
Solid, Hard. These words both relate to the internal constitution of bodies; but hardnotes a more impenetrable nature or a firmer adherence of the component parts than solid. Hard is opposed to soft, and solid to fluid, liquid, open, or hollow. Wood is usually solid; but some kinds of wood are hard, and others are soft. "Repose you there; while I [return] to this hard house, More harder than the stones whereof 't is raised." (Shak) "I hear his thundering voice resound, And trampling feet than shake the solid ground." (Dryden)
Origin: L. Solidus, probably akin to sollus whole, entire, Gr., cf. F. Solide. Cf. Consolidate,Soda, Solder, Soldier, Solemn.
1. A substance that is held in a fixed form by cohesion among its particles; a substance not fluid.
2. <geometry> A magnitude which has length, breadth, and thickness; a part of space bounded on all sides. Solid of revolution.
<geometry> See Revolution.
Source: Websters Dictionary
(01 Mar 1998)
solid breeder <radiobiology> Solid lithium-bearing compounds, usually ceramics such as Li2O and LiAlO2, which might be used in the blanket of a D-T fusion reactor to produce (breed) additional tritium fuel from the n + Li = He + T (+n) reactions.
(09 Oct 1997)
solid lesion of spleen <radiology> Granulomatous disease, most often TB and histoplasmosis, less often sarcoid, metastasis, melanoma, lymphoma, breast, lung, primary mass, haemangioma, haemangiosarcoma, lymphangioma, infarction
(12 Dec 1998)
solid oedema Infiltration of the subcutaneous tissues by mucoid material, as in myxoedema.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • solid
    °íüÀÇ,°íÇüÀÇ,´Ü´ÜÇÑ,½Ç¼ÓÀÖ´Â,¼ø¼öÇÑ,ưưÇÑ,°ß°íÇÑ,ÀÔüÀÇ
  • color phase
    À¯Àü¿¡ ÀÇÇÑ Ã¼»ö º¯È­;°èÀý¿¡ µû¸¥ ¸ðÀÇÀÇ º¯È­»ö
  • phase
    º¯È­;¹ß´ÞÀÇ ´Ü°è;Çü¼¼;±¹¸é;¸é;»ó;À§»óÀ¸·Î ³ª´©´Ù
  • phase angle
    À§»ó°¢
  • phase contrast
    À§»óÂ÷
  • phase microscope
    À§»óÂ÷ Çö¹Ì°æ
  • phase modulation
    À§»ó º¯Á¶
  • phase zero
    (°èȹ µîÀÇ) Áغñ ´Ü°è;Á¦·Î ´Ü°è
  • regular solid
    Á¤´Ù¸éü
  • semi solid
    ¹Ý °íü
  • solid
    °íüÀÇ;¼ÓÀÌ ºñÁö ¾ÊÀº;ÀÔ¹æÀÇ;ÀÔüÀÇ;£Àº;µÎ²¨¿î;°ß½ÇÇÑ;ưưÇÑ;¶È °°Àº;¼ø¼öÇÑ;¿ÏÀüÇÑ;´Ü°áµÈ;½Å·ÚÇÒ ¼ö ÀÖ´Â;¿¬¼ÓµÈ;(º¹Çվ)ÇÏÀÌǾøÀÌ µÈ;»çÀ̰¡ ÁÁÀº;ÈǸ¢ÇÑ;¸ÚÁø;°íü;ÀÔ(¹æ)ü
  • solid fuel
    °íü¿¬·á
  • solid geometry
    ÀÔü ±âÇÏ
  • solid measure
    ºÎÇÇ;üÀû;¿ëÀû
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á